Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.98 EUR | -0.28% | -0.52% | -22.72% |
08:56am | Bayer's Prostate Cancer Combo Extends Progression-Free Survival in Late-stage Trial | MT |
08:08am | Bayer's Nubeqa Meets Key Goal in Late-Stage Prostate Cancer Trial | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.72% | 27.86B | |
+61.53% | 848B | |
+34.31% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.66% | 234B | |
+15.48% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Transcript : Bayer Aktiengesellschaft - Special Call